James Brian Windsor bought $9,987 of RNTX
President and COO at Aileron Therapeutics, Inc.. 5,076 shares at an average of $1.97, traded Nov 20, 2023, filed Nov 21, 2023.
Score components
- +20RolePresident
- 0Trade size$10k at market
- +10Relative to holdingsHoldings up 11035%
- +8Price context41% below the 52-week high
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +65.4%, 3m +159.3%, 6m +107.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000950170-23-065545, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 20, 2023 | POpen-market purchase Common Stock | +5,076 | $1.97 | $9,987 | 5,122 | Nov 21, 2023 |
Related signals
Other insiders at Aileron Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 50Moderate | RNTXbuy Aileron Therapeutics, Inc. | Josef H Von Rickenbach director | $50k 47,060 shares | +305% | |
| 38Weak | RNTXbuy Aileron Therapeutics, Inc. | James Brian Windsor See Remarks | $25k 25,000 shares | +1222% | |
| 26Weak | RNTXbuy Aileron Therapeutics, Inc. | Voss Capital, LLC owner | $128k 104,183 shares | +13% | |
| 29Weak | RNTXbuy Aileron Therapeutics, Inc. | Voss Capital, LLC owner | $423k 306,050 shares | +44% | |
| 33Weak | RNTXbuy Aileron Therapeutics, Inc. | James Brian Windsor President and CEO | $898 400 shares | - | |
| 12Weak | RNTXsell Aileron Therapeutics, Inc. | University Of Texas/texas Am Investment Management Co owner | $22k 6,607 shares | -0% | |
| 21Weak | RNTXsell Aileron Therapeutics, Inc. | University Of Texas/texas Am Investment Management Co owner | $81k 24,671 shares | -1% | |
| 18Weak | RNTXsell Aileron Therapeutics, Inc. | University Of Texas/texas Am Investment Management Co owner | $41k 12,315 shares | -1% | |
| 21Weak | RNTXsell Aileron Therapeutics, Inc. | University Of Texas/texas Am Investment Management Co owner | $85k 20,315 shares | -1% | |
| 23Weak | RNTXsell Aileron Therapeutics, Inc. | University Of Texas/texas Am Investment Management Co owner | $139k 31,151 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.